Analystreport

Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its price target raised by analysts at Cantor Fitzgerald from $22.00 to $35.00. They now have an "overweight" rating o

Celldex Therapeutics, Inc.  (CLDX) 
Last celldex therapeutics, inc. earnings: 11/12 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celldex.com